These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 20648612

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS.
    Lancet; 1996 Oct 26; 348(9035):1133-8. PubMed ID: 8888167
    [Abstract] [Full Text] [Related]

  • 23. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
    Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ.
    J Hum Virol; 1997 Oct 26; 1(1):19-29. PubMed ID: 10195227
    [Abstract] [Full Text] [Related]

  • 24. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
    Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J.
    AIDS; 1998 Dec 24; 12(18):2481-8. PubMed ID: 9875587
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
    Okroj M, Spiller OB, Korodi Z, Tedeschi R, Dillner J, Blom AM.
    Vaccine; 2007 Nov 23; 25(48):8102-9. PubMed ID: 17964697
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
    Guihot A, Dupin N, Marcelin AG, Gorin I, Bedin AS, Bossi P, Galicier L, Oksenhendler E, Autran B, Carcelain G.
    J Infect Dis; 2006 Oct 15; 194(8):1078-88. PubMed ID: 16991082
    [Abstract] [Full Text] [Related]

  • 32. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1.
    Hbid O, Belloul L, Fajali N, Ismaili N, Duprez R, Tanguy M, Benomar H, Tahri el H, Gessain A, Huerre M.
    Pathology; 2005 Aug 15; 37(4):288-95. PubMed ID: 16194827
    [Abstract] [Full Text] [Related]

  • 33. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.
    Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Buttò S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, Goebel FD, Hintermaier R, Enders G, Regamey N, Wernli M, Stürzl M, Rezza G, Ensoli B.
    J Med Virol; 2001 Sep 15; 65(1):123-32. PubMed ID: 11505454
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients.
    Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P.
    N Engl J Med; 1998 Nov 05; 339(19):1358-63. PubMed ID: 9801396
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
    Mohanna S, Maco V, Bravo F, Gotuzzo E.
    Int J Infect Dis; 2005 Sep 05; 9(5):239-50. PubMed ID: 16095940
    [Abstract] [Full Text] [Related]

  • 39. HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.
    Wamburu G, Masenga EJ, Moshi EZ, Schmid-Grendelmeier P, Kempf W, Orfanos CE.
    Eur J Dermatol; 2006 Sep 05; 16(6):677-82. PubMed ID: 17229611
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.